Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
2JUN

US bans entry from DRC, Uganda, S Sudan

3 min read
09:17UTC

On 18 May the United States imposed a 21-day entry ban on nationals of three African states, including green-card holders, three days before WHO formally advised against exactly such restrictions.

ScienceDeveloping
Key takeaway

The US entry ban runs against live WHO advice for the first time since the 2014 Ebola response.

On 18 May the United States imposed a 21-day entry ban on nationals of the Democratic Republic of Congo, Uganda and South Sudan, including green-card holders 1. US citizens may still enter but face enhanced public-health screening at George Bush Intercontinental Airport in Houston from 26 May 2. South Sudan was included despite having no confirmed Bundibugyo cases, on the stated logic of porous borders with the DRC 3. The measure followed three days after WHO declared the Bundibugyo emergency .

The ban came first; four days later WHO's Emergency Committee issued Temporary Recommendations advising against travel and trade restrictions, and the ban has not been lifted since 4. Africa CDC publicly opposed the restrictions on 19 May 5. A major power has now banned travel against live WHO advice during an active emergency for the first time since the West Africa Ebola crisis of 2014, whose travel-ban failures the IHR exit-screening model was written to replace.

Entry bans push exposed travellers toward unscreened land routes and onward third-country flights, the exact behaviour exit screening at source is built to capture, and they discourage the honest disclosure border co-operation depends on. Bans also operate on nationality rather than exposure: a green-card holder WHO has not left the US in a year falls under the bar, while the screening of returning US citizens at Houston targets actual travel history. The 21-day entry ban therefore catches people by passport, not by where they have been.

Washington's reach for a border measure rather than a deployment has a structural backdrop. The USAID outbreak-response unit that would have surged personnel to Ituri had already been disbanded before the emergency , leaving entry restriction as one of the few levers still readily available. For readers planning travel, the practical effect is narrow: the bar falls on green-card holders and nationals of the three countries, while US citizens face questions and a temperature check at Houston, not exclusion.

Deep Analysis

In plain English

On 18 May 2026, the United States banned entry for nationals of three countries: the Democratic Republic of Congo, Uganda, and South Sudan. The ban includes people with US permanent residency (green cards). South Sudan was included even though no Ebola cases had been confirmed there. Public-health experts consistently oppose travel bans during Ebola outbreaks because they do not stop the virus, they drive sick or worried people to use unofficial routes where they cannot be monitored. They also make healthcare workers from affected countries reluctant to volunteer to help, which is exactly the opposite of what a response needs. Four days after the ban was imposed, the WHO's own expert committee formally recommended against travel or trade restrictions.

Deep Analysis
Root Causes

The US entry ban tracks a structural gap left by the dismantling of USAID's outbreak-response unit : with no 90-person CDC field presence deployable to Ituri, the only publicly visible US action available is a border measure. Entry bans are administratively simple and politically legible; field surge deployment requires an institutional apparatus the current US government no longer has.

South Sudan's inclusion despite zero cases reflects the conflation of geographic proximity with epidemic risk. The Ituri-South Sudan border does carry genuine surveillance risk given ungated population movement, but including South Sudan in a travel ban without a confirmed case is epidemiologically unjustifiable and was designed to signal political decisiveness rather than epidemiological precision.

What could happen next?
  • Risk

    Travel bans that push affected-country nationals to use informal border crossings reduce the WHO's ability to conduct exit screening, the single most evidence-based border measure for Ebola.

  • Consequence

    Uganda and South Sudan nationals working abroad in healthcare roles may delay return to their countries of origin, reducing the human resource pool available for the Ituri response surge.

First Reported In

Update #4 · Ebola triples, response misfires

STAT News· 24 May 2026
Read original
Different Perspectives
Imperial College London / Cori and Ferguson
Imperial College London / Cori and Ferguson
Anne Cori and Neil Ferguson place the case-fatality ratio at 30 to 40 per cent and read the 6.8-to-1 suspected-to-confirmed ratio as evidence that the laboratory figure understates true lethality. Many people die before a swab reaches them.
Uganda / Diana Atwine
Uganda / Diana Atwine
Diana Atwine's ministry traced the imported Kampala index case and leant on protocols rehearsed in Uganda's 2022 Sudan ebolavirus response, which contained 142 cases in 113 days without a vaccine. Nine confirmed cases now test whether that playbook holds across two districts.
United States / HHS
United States / HHS
Washington imposed a 21-day entry ban on DRC, Uganda and South Sudan nationals against WHO advice, and sought a 50-bed quarantine site in Nairobi that a Kenyan court suspended on 29 May. The posture rests on a thin federal bench with vacant senior public-health roles.
WHO / Tedros Adhanom Ghebreyesus
WHO / Tedros Adhanom Ghebreyesus
Tedros Adhanom Ghebreyesus called the outbreak 'outpacing us' on 25 May and visited Ituri on 28 May, arguing that stopping transmission depends entirely on humanitarian access. WHO opposes any restriction of travel to or trade with DRC or Uganda.
Africa CDC / Jean Kaseya
Africa CDC / Jean Kaseya
Jean Kaseya declared the continental emergency before WHO and opposed the US travel ban as punishment by passport rather than by exposure. The Africa CDC raised nearly $500 million in days and frames the response as African-led, coordinated from Addis Ababa rather than waiting on Geneva.
European Union / ECDC
European Union / ECDC
ECDC activated an EU Health Task Force, assessed European Bundibugyo import risk as very low, and flagged the recombinant clade Ib/IIb mpox strain in four countries as a surveillance watch item. Both calls reflect the same post-2024 IHR mandate: ECDC acts as a continental early-warning layer rather than waiting for WHO Disease Outbreak News guidance.